Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 85 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
841 13.0 months Castration-resistant prostate cancer 4 Chemotherapy
Università Federico II Italy 1/2011
Treatment Details: Patients: This study involved 45 male patients with castration-resistant prostate cancer who had been previously treated with docetaxel. The median age of the group was 65 years with a ran
 
842 13.0 months Ovarian cancer 4 Biologic therapy
Chemotherapy
Catholic University of Campobasso Italy 5/2011
Treatment Details: Patients: This study involved 45 women with ovarian cancer who had previously received treatment. The median age was 59 years. Treatment: Patients were treated with the chemotherapy ag
 
843 13.0 months Unresectable Stage III NSCLC 3 Chemotherapy
Radiation
Surgery
Catholic University Italy 2/2006
Treatment Details: Patients: This Phase II study involved 46 patients (37 men, 9 women, median age 64 years) with advanced inoperable non-small-cell lung cancer. Treatment: Treatment consisted of radiation
 
844 13.0 months Advanced NSCLC 4 Chemotherapy
Medical University Hospital Austria 5/2006
Treatment Details: Patients: This Phase III trial involved a total of 352 patients with advanced non-small-cell lung cancer. There were 255 men and 97 women and the ages ranged from 29 to 77 (the median age w
 
845 13.0 months Mesothelioma 5 Chemotherapy
Surgery
Brigham and Women's Hospital United States 4/2006
Treatment Details: Patients: This phase I to II study involved 61 patients with mesothelioma, 44 of which received the combination (surgery and chemotherapy) treatment. These patients had a median age of 71 y
 
846 13.0 months Metastatic colorectal cancer 5 Chemotherapy
New York University Cancer Institute United States 12/2007
Treatment Details: Patients: This phase II study involved 55 patients with metastatic colorectal cancer. The mean (average) age was 81 years, ranging from 75-90. Men made up 52.7% of these patients, and wom
 
847 13.0 months Advanced hepatocellular carcinoma 4 Chemotherapy
Karmanos Cancer Institute United States 9/2005
Treatment Details: Patients: This Phase II study involved 38 patients with advanced hepatocellular cancer, fifteen of whom had metastases (including lung, liver, bone, and lymph nodes). Twenty-six patients we
 
848 13.0 months Metastatic colorectal cancer 4 Chemotherapy
Vejle Hospital Denmark 1/2004
Treatment Details: Patients: This Phase II study involved 97 patients with metastatic colorectal cancer. Treatment: The treatment consisted of several drugs –UFT (uracil and tegafur), Leucovorin, and Mitomy
 
849 13.0 months Metastatic colorectal cancer 4 Chemotherapy
Vejle Hospital Denmark 1/2004
Treatment Details: Patients: This Phase II study involved 97 patients with metastatic colorectal cancer. Treatment: The treatment consisted of several drugs –UFT (uracil and tegafur), Leucovorin, and Mitomy
 
850 13.0 months Malignant Pleural Mesothelioma 4 Alternative
Chemotherapy
University of Turin Italy 4/2003
Treatment Details: Patients: This Phase II study involved 64 patients with malignant pleural mesothelioma who had not had chemotherapy previously and who could not be cured by surgery alone. Treatment: Pa
 
Page 85 of 187  | Previous Page  | Next Page